<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03187821</url>
  </required_header>
  <id_info>
    <org_study_id>iface2pi</org_study_id>
    <nct_id>NCT03187821</nct_id>
  </id_info>
  <brief_title>Comparison of Superior vs Nasal/Temporal Laser Peripheral Iridotomy in Primary Angle Closure</brief_title>
  <official_title>Comparison of Superior vs Nasal/Temporal Laser Peripheral Iridotomy in Primary Angle Closure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Venkatesh Rengaraj</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aravind Eye Care System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if location of laser peripheral iridotomy (LPI)
      that is the standard of care treatment for angle closure glaucoma is related to changes in
      post-operative intraocular pressure (IOP), endothelial cell count,anterior chamber angle
      morphology and onset of new visual disturbances.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study hypothesis: Location of laser peripheral iridotomy affects occurrence of post-operative
      dysphotopsia symptoms, intraocular pressure, anterior chamber angle morphology and corneal
      endothelial cell count Study design: Multicenter randomized, prospective, single masked trial
      Trial setting: Hospitals Trial type: Treatment

      Interventions: South Indian subjects aged 30 years or greater, with primary angle closure
      suspect (PACS) or primary angle closure/ primary angle closure glaucoma(PAC/PACG) will be
      randomized to either bilateral superior or nasal/temporal laser peripheral iridotomy.
      Subjects will undergo noninvasive testing and imaging studies to measure IOP, anterior
      chamber angle morphology and endothelial cell count and asked to answer a questionnaire at
      baseline and again at 2 weeks and 6 months after treatment Primary outcome measures:
      Occurrence of new self-reported general eye or dysphotopsia symptoms.

      Secondary outcome measures: intraocular pressure, anterior chamber and anterior chamber angle
      morphology, endothelial cell count.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of new self-reported general eye or dysphotopsia symptoms</measure>
    <time_frame>6 Months</time_frame>
    <description>Questionnaire using a Likert scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraocular pressure</measure>
    <time_frame>6 Months</time_frame>
    <description>measured in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anterior chamber angle morphology</measure>
    <time_frame>6 Months</time_frame>
    <description>measured in micrometers using anterior segment optical coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal endothelial cell count</measure>
    <time_frame>6 Months</time_frame>
    <description>measured on a continuous scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Choroidal thickness</measure>
    <time_frame>6 Months</time_frame>
    <description>measured in micrometers using enhanced depth optical coherence tomography</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1000</enrollment>
  <condition>Glaucoma, Angle-Closure</condition>
  <arm_group>
    <arm_group_label>Superior</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laser peripheral iridotomy done at superior part of iris.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal/temporal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laser peripheral iridotomy done at temporal/nasal part of iris.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laser peripheral iridotomy</intervention_name>
    <description>location of laser peripheral iridotomy</description>
    <arm_group_label>Superior</arm_group_label>
    <arm_group_label>Nasal/temporal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of PACS or PAC/PACG in at least one eye

        Exclusion Criteria:

          -  bilaterally pseudophakic

          -  prior iridotomy, iridoplasty, or incisional glaucoma surgery in either eye

          -  signs or symptoms consistent with acute angle closure at time of enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rengaraj Venkatesh, DNB</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aravind Eye Hospital, Pondicherry</affiliation>
  </overall_official>
  <reference>
    <citation>Vera V, Naqi A, Belovay GW, Varma DK, Ahmed II. Dysphotopsia after temporal versus superior laser peripheral iridotomy: a prospective randomized paired eye trial. Am J Ophthalmol. 2014 May;157(5):929-35. doi: 10.1016/j.ajo.2014.02.010. Epub 2014 Feb 14.</citation>
    <PMID>24531024</PMID>
  </reference>
  <reference>
    <citation>Jiang Y, Chang DS, Foster PJ, He M, Huang S, Aung T, Friedman DS. Immediate changes in intraocular pressure after laser peripheral iridotomy in primary angle-closure suspects. Ophthalmology. 2012 Feb;119(2):283-8. doi: 10.1016/j.ophtha.2011.08.014. Epub 2011 Oct 29.</citation>
    <PMID>22036632</PMID>
  </reference>
  <reference>
    <citation>Kumar RS, Baskaran M, Friedman DS, Xu Y, Wong HT, Lavanya R, Chew PT, Foster PJ, Aung T. Effect of prophylactic laser iridotomy on corneal endothelial cell density over 3 years in primary angle closure suspects. Br J Ophthalmol. 2013 Mar;97(3):258-61. doi: 10.1136/bjophthalmol-2012-302013. Epub 2012 Nov 30.</citation>
    <PMID>23203700</PMID>
  </reference>
  <reference>
    <citation>How AC, Baskaran M, Kumar RS, He M, Foster PJ, Lavanya R, Wong HT, Chew PT, Friedman DS, Aung T. Changes in anterior segment morphology after laser peripheral iridotomy: an anterior segment optical coherence tomography study. Ophthalmology. 2012 Jul;119(7):1383-7. doi: 10.1016/j.ophtha.2012.01.019. Epub 2012 Mar 10.</citation>
    <PMID>22410350</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>June 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2017</study_first_posted>
  <last_update_submitted>June 14, 2017</last_update_submitted>
  <last_update_submitted_qc>June 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Aravind Eye Care System</investigator_affiliation>
    <investigator_full_name>Venkatesh Rengaraj</investigator_full_name>
    <investigator_title>Clinical Research Coordinator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma, Angle-Closure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

